Prostate cancer decisions — 2025

The Board denied the Veteran's claim for a total disability rating based on individual unemployability due to service-connected disabilities, as the evidence did not show that his service-connected conditions rendered him unable to secure or follow substantially gainful employment.

The Board denied an earlier effective date for the grant of service connection for prostate cancer with urinary incontinence and erectile dysfunction, as the Veteran's claims were received within one year after the enactment of the PACT Act on August 10, 2022.

The Board denied the Veteran's claim for service connection for prostate cancer due to a lack of evidence showing a current diagnosis.

The Board denied service connection for benign tremors, COPD, prostate cancer, and heart disease as the evidence did not support a conclusion that these conditions were incurred in or aggravated by active military service.

The Board granted service connection for prostate cancer and lumbar spine degenerative disc disease, but denied service connection for a left ankle disability. The right shoulder and right eye disabilities were remanded for further examination.

The Board denied the veteran's claims for increased ratings and other benefits, finding that his conditions did not meet the criteria for higher ratings.

The Board remands the claims for service connection for prostate cancer, brain cancer, and erectile dysfunction to verify in-service toxic exposure other than asbestos and Agent Orange.

The Board granted an initial 40 percent evaluation for service-connected residuals of prostate cancer, effective from the date of claim. The other issues were remanded.

The Board granted service connection for prostate cancer, finding it to be related to the Veteran's exposure to contaminants in the water supply at Camp Lejeune.

The Board remands the claim for service connection for prostate cancer to verify the Veteran's claimed exposure to herbicide agents during active military service in Korea and to obtain a VA examination.

The Board granted service connection for bladder cancer, prostate cancer, and erectile dysfunction as secondary to the service-connected prostate cancer.

The Board remands the case to obtain an adequate VA examination to determine the current severity of the Veteran's prostate cancer and clarify whether it is active or in remission.

The Board remands the claims for service connection for diabetes type II, GERD, prostate cancer, and hypertension as further development is necessary to determine if there is a nexus between these conditions and the Veteran's military service, including exposure to herbicides.

The Board granted earlier effective dates of April 28, 2017, for service connection for diabetes mellitus, type II, right and left lower extremity peripheral neuropathy, and a total disability rating based on unemployability due to service-connected disabilities (TDIU), but denied an earlier effective date for prostate cancer residuals.

The Board denied service connection for prostate cancer and coronary calcification, finding no evidence of a medical nexus between the conditions and toxic exposure or service.

The Board remands the claim for service connection of prostate cancer to obtain an addendum opinion that addresses the Veteran's contention of a link between his condition and in-service exposure.

The Veteran's claim for special monthly compensation (SMC) based on the need for regular aid and attendance due to his service-connected disabilities was granted.

The Board remands the claims for an increased rating and earlier effective date for the Veteran's heart disability, an increased rating for prostate cancer, SMC based on the need for aid and attendance, and an earlier effective date for TDIU due to inadequate VA examinations.

The Board remands the claims for service connection for prostate and throat cancers due to a lack of proper development regarding potential exposures to PFAS and herbicides during active duty.

The Board granted a 100 percent rating for prostate cancer due to its recurrence during the appeal period.